238 results on '"Kruse, Niels"'
Search Results
2. Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression
3. TREM2 expression in the brain and biological fluids in prion diseases
4. Neurofilament Light Chain Serum Levels Mirror Age and Disability in Secondary Progressive Multiple Sclerosis: A Cross-Sectional Study.
5. Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease
6. Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases
7. Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease
8. Quantification of Alpha-Synuclein in Biological Fluids by Electrochemiluminescence-Based Detection
9. Validation of a commercially available enzyme-linked immunoabsorbent assay for the quantification of human α-Synuclein in cerebrospinal fluid
10. Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study
11. Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt–Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress
12. Neurofilament light chains in serum as biomarkers of axonal damage in early MS lesions: a histological–serological correlative study
13. Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodies
14. TREM2 expression in the brain and biological fluids in prion diseases
15. Quantification of CSF biomarkers using an electrochemiluminescence-based detection system in the differential diagnosis of AD and sCJD
16. Extracellular vesicle sorting of α-Synuclein is regulated by sumoylation
17. Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of α-synuclein and other proteins in cerebrospinal fluid
18. Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline
19. Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases
20. Baseline Cerebrospinal Fluid 0̆3b1-Synuclein in Parkinson's Disease Is Associated with Disease Progression and Cognitive Decline
21. Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies
22. Natalizumab analogon therapy is effective in a B cell-dependent multiple sclerosis model
23. Systematic Assessment of 10 Biomarker Candidates Focusing on α‐Synuclein‐Related Disorders
24. Differential expression of BDNF mRNA splice variants in mouse brain and immune cells
25. A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation
26. Recommendations to standardize preanalytical confounding factors in Alzheimerʼs and Parkinsonʼs disease cerebrospinal fluid biomarkers: an update
27. Anesthesia triggers drug delivery to experimental glioma in mice by hijacking caveolar transport
28. Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates
29. Molecular alterations in the cerebellum of sporadic Creutzfeldt–Jakob disease subtypes with DJ-1 as a key regulator of oxidative stress
30. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis
31. HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype
32. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis
33. Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates
34. Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis
35. Evaluation of diagnostic relevance of mRNA levels in peripheral blood: predictive value for mortality in hemodialysis patients
36. Effects of Oncostatin M on Human Cerebral Endothelial Cells and Expression in Inflammatory Brain Lesions
37. Genetic polymorphism of the tumor necrosis factor (TNF)-α promoter region in families with localized early-onset periodontitis
38. Autoantibodies to BP180 Associated with Bullous Pemphigoid Release Interleukin-6 and Interleukin-8 from Cultured Human Keratinocytes
39. Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson’s Disease Progression
40. Genomic NGFB variation and multiple sclerosis in a case control study
41. Genetic variation at position –1082 of the interleukin 10 (IL10) promotor and the outcome of multiple sclerosis
42. Antibody‐based methods for the measurement of α‐synuclein concentration in human cerebrospinal fluid – method comparison and round robin study
43. O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACH
44. Lack of efficacy of mitoxantrone in primary progressive Multiple Sclerosis irrespective of pharmacogenetic factors: A multi-center, retrospective analysis
45. [P4-151]: ALPHA-SYNUCLEIN BIOMARKER ANALYSIS: ANALYTICAL PERFORMANCE AND INTER-LABORATORY PRECISION USING A NEW COLORIMETRIC ELISA
46. Validation of electrochemiluminescence assays for highly sensitive and reproducible quantification of α-synuclein in cerebrospinal fluid
47. Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease
48. Antibody‐based methods for the measurement of α‐synuclein concentration in human cerebrospinal fluid – method comparison and round robin study.
49. Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study
50. Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt–Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.